Breaking News

PSI CRO Appoints Regulatory Affairs Head

By Kristin Brooks | February 26, 2014

Schmoetzer brings extensive industry experience

Dr. Gabriele Schmoetzer has been appointed head of regulatory affairs, Germany, at PSI CRO. Dr. Schmoetzer will supervise all regulatory-related activities for Germany, Austria and Switzerland.
Dr. Schmoetzer brings 24 years of clinical research experience, having worked for small, mid-size and large CROs. She has held positions in international and global project management, regulatory affairs, where she has held managerial positions, and has been responsible for clinical trial submissions in Germany and a number of other EU countries. Dr. Schmoetzer has experience with RA-specific processes and brings both technical expertise and extensive knowledge of the clinical trial regulatory environment.

Related Compliance:

blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus